-+ 0.00%
-+ 0.00%
-+ 0.00%

Is Argan (AGX) A Bargain As Strong Earnings Raise Fresh Valuation Questions?

Simply Wall St·09/03/2026 07:24:24
Listen to the news

What Argan’s latest earnings tell you

Argan (AGX) just released second quarter and first half 2026 results, with higher sales, net income and earnings per share than the same periods a year earlier. That is drawing fresh attention to the stock.

Despite the stronger second quarter, Argan’s recent share price has been under pressure, with a 30-day share price return of down 30.75% and a 90-day share price return of down 40.47%, even though the 1-year total shareholder return is 81.63% and the 3-year total shareholder return is very large. This points to long-term momentum that has cooled sharply in recent months.

Compare Argan’s earnings momentum and recent share price pullback with a curated 54 high quality undervalued stocks that pairs solid fundamentals with recent market pressure.

Bulls point to Argan’s strong recent earnings and longer term returns. Bears focus on the sharp pullback and question what the stock now reflects. Which side do the current valuation numbers support?

Most Popular Narrative: 39.6% Undervalued

Argan’s most followed narrative pegs fair value at $679.80 based on discounted future earnings, compared with the latest close of $410.40. That gap is what drives the current debate.

Record backlog and continued project wins across gas, renewables, water treatment, and recycling plants provide multi-year revenue visibility, indicating potential for increased operating leverage and higher gross margins as larger projects are executed successfully. Argan's reputation for on-time, on-budget project delivery and its expanded workforce enable it to handle more and larger projects than competitors, which is likely to support earnings growth and improve net margin stability over time.

Read the complete narrative.

Want to see what sits behind that fair value for Argan? The narrative leans heavily on brisk revenue expansion, firm margins, and a premium earnings multiple. Curious which specific assumptions push the valuation so far above today’s price? The full breakdown shows exactly how those inputs stack up.

Result: Fair Value of $679.80 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Argan’s heavy tilt toward large gas power projects and reliance on a small set of complex EPC contracts could quickly challenge that bullish narrative if conditions shift.

Find out about the key risks to this Argan narrative.

Another View on Argan’s Valuation

The main narrative around Argan leans on discounted earnings and a high implied P/E. Yet the current P/E of 35.7x is above the US Construction industry at 32.4x and above a fair ratio of 31.2x. That suggests investors are already paying up. How comfortable are you with that premium?

See what the numbers say about this price — find out in our valuation breakdown.

NYSE:AGX P/E Ratio as at Sep 2026
NYSE:AGX P/E Ratio as at Sep 2026

Next Steps

Given the mixed signals around Argan’s recent performance and valuation, it makes sense to move quickly and inspect the underlying data yourself. To weigh the upside against the potential downsides in a balanced way, start with the 2 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Argan?

If Argan has you thinking harder about valuation and timing, do not stop there. Broadening your list can help you spot opportunities others overlook.

  • Target steady compounding potential by reviewing a 11 dividend fortresses that highlights companies returning cash to shareholders through sizeable yields.
  • Hunt for quality at a discount by scanning a 20 high quality undiscovered gems that spotlights stocks with strong fundamentals that many investors may be ignoring.
  • Pressure test your risk tolerance by checking a 75 resilient stocks with low risk scores that focuses on businesses with more resilient profiles and lower risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.